These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25942485)

  • 21. Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.
    DeRan M; Yang J; Shen CH; Peters EC; Fitamant J; Chan P; Hsieh M; Zhu S; Asara JM; Zheng B; Bardeesy N; Liu J; Wu X
    Cell Rep; 2014 Oct; 9(2):495-503. PubMed ID: 25373897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.
    Santinon G; Pocaterra A; Dupont S
    Trends Cell Biol; 2016 Apr; 26(4):289-299. PubMed ID: 26750334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
    Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
    Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sizing up lung stem cells.
    Rock JR
    Dev Cell; 2014 Jul; 30(2):112-4. PubMed ID: 25073150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute stimulation of glucose influx upon mitoenergetic dysfunction requires LKB1, AMPK, Sirt2 and mTOR-RAPTOR.
    Liemburg-Apers DC; Wagenaars JA; Smeitink JA; Willems PH; Koopman WJ
    J Cell Sci; 2016 Dec; 129(23):4411-4423. PubMed ID: 27793977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle.
    Dreyer HC; Fujita S; Cadenas JG; Chinkes DL; Volpi E; Rasmussen BB
    J Physiol; 2006 Oct; 576(Pt 2):613-24. PubMed ID: 16873412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma.
    Zhao F; Yang Z; Chen Y; Zhou Q; Zhang J; Liu J; Wang B; He Q; Zhang L; Yu Y; Liu P
    World Neurosurg; 2018 Sep; 117():e269-e279. PubMed ID: 29902598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP1--friend and foe.
    Yee KS; O'Neill E
    Cell Cycle; 2010 Apr; 9(8):1447-8. PubMed ID: 20372091
    [No Abstract]   [Full Text] [Related]  

  • 30. Computational analysis of an autophagy/translation switch based on mutual inhibition of MTORC1 and ULK1.
    Szymańska P; Martin KR; MacKeigan JP; Hlavacek WS; Lipniacki T
    PLoS One; 2015; 10(3):e0116550. PubMed ID: 25761126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
    Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
    EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
    J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal regeneration: YAP-tumor suppressor and oncoprotein?
    Li VS; Clevers H
    Curr Biol; 2013 Feb; 23(3):R110-2. PubMed ID: 23391384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol.
    Jagannathan R; Schimizzi GV; Zhang K; Loza AJ; Yabuta N; Nojima H; Longmore GD
    Mol Cell Biol; 2016 Oct; 36(20):2526-42. PubMed ID: 27457617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippo signaling promotes JNK-dependent cell migration.
    Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting YAP and Hippo signaling pathway in liver cancer.
    Liu AM; Xu MZ; Chen J; Poon RT; Luk JM
    Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mst1/2 Kinases Modulate Glucose Uptake for Osteoblast Differentiation and Bone Formation.
    Li W; Deng Y; Feng B; Mak KK
    J Bone Miner Res; 2018 Jun; 33(6):1183-1195. PubMed ID: 29474739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippo signaling dysfunction induces cancer cell addiction to YAP.
    Han H; Yang B; Nakaoka HJ; Yang J; Zhao Y; Le Nguyen K; Bishara AT; Mandalia TK; Wang W
    Oncogene; 2018 Dec; 37(50):6414-6424. PubMed ID: 30068939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.